Prasad Sweta, Kashyap Rajpal Singh, Deopujari Jayant Y, Purohit Hemant J, Taori Girdhar M, Daginawala Hatim F
Biochemistry Research Laboratory, Central India Institute of Medical Sciences, 88/2, Bajaj Nagar, Nagpur-440010, Maharashtra, India.
BMC Complement Altern Med. 2007 Nov 6;7:36. doi: 10.1186/1472-6882-7-36.
Atherothrombotic diseases such as myocardial or cerebral infarction are serious consequences of the thrombus formed in blood vessels. Thrombolytic agents are used to dissolve the already formed clots in the blood vessels; however, these drugs have certain limitations which cause serious and sometimes fatal consequences. Herbal preparations have been used since ancient times for the treatment of several diseases. Herbs and their components possessing antithrombotic activity have been reported before; however, herbs that could be used for thrombolysis has not been reported so far. This study's aim was to investigate whether herbal preparations (aqueous extract) possess thrombolytic activity or not.
An in vitro thrombolytic model was used to check the clot lysis effect of six aqueous herbal extracts viz., Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn along with Streptokinase as a positive control and water as a negative control.
Using an in vitro thrombolytic model, Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn showed 19.3%, 14.5%, 20.3%, 17.8%, 75.6% and 41.8% clot lysis respectively . Among the herbs studied Fagonia arabica showed significant % of clot lysis (75.6%) with reference to Streptokinase (86.2%).
Through our study it was found that Dhamasa possesses thrombolytic properties that could lyse blood clots in vitro; however, in vivo clot dissolving properties and active component(s) of Dhamasa for clot lysis are yet to be discovered. Once found Dhamasa could be incorporated as a thrombolytic agent for the improvement of patients suffering from Atherothrombotic diseases.
动脉粥样硬化血栓形成性疾病,如心肌梗死或脑梗死,是血管内形成血栓的严重后果。溶栓药物用于溶解血管中已经形成的血栓;然而,这些药物有一定局限性,会导致严重且有时致命的后果。草药制剂自古以来就被用于治疗多种疾病。之前已有报道称草药及其成分具有抗血栓活性;然而,迄今为止尚未有可用于溶栓的草药报道。本研究的目的是调查草药制剂(水提取物)是否具有溶栓活性。
采用体外溶栓模型,检测六种草药水提取物即印度防己、茜草、牛心朴子、光果甘草、阿拉伯骆驼蓬和假马齿苋的溶栓效果,同时以链激酶作为阳性对照,水作为阴性对照。
使用体外溶栓模型,印度防己、茜草、牛心朴子、光果甘草、阿拉伯骆驼蓬和假马齿苋的溶栓率分别为19.3%、14.5%、20.3%、17.8%、75.6%和41.8%。在所研究的草药中,阿拉伯骆驼蓬相对于链激酶(86.2%)显示出显著的溶栓率(75.6%)。
通过我们的研究发现,达马萨具有溶栓特性,可在体外溶解血栓;然而,达马萨在体内的溶栓特性以及用于溶栓的活性成分尚未被发现。一旦发现,达马萨可作为一种溶栓剂用于改善患有动脉粥样硬化血栓形成性疾病的患者。